TrialScientific reports2024

Rivaroxaban versus vitamin K antagonist treatment on the progression of coronary calcification: the IRIVASC-trial.

Robert Stöhr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.